or Try an Advanced Search...

    Technical Analysis for BCDA - BioCardia, Inc.

    Grade Last Price % Change Price Change
    F 0.40 2.79% 0.01
    BCDA closed up 2.07 percent on Wednesday, May 8, 2024, on 14 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Flat Up
    Historical BCDA trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 1.75%
    Stochastic Reached Overbought Strength 1.75%
    Earnings Movers Other 1.75%
    Weak + Overbought Other 1.75%
    BB Squeeze + Upper Band Touch Range Contraction 1.75%
    Gapped Up Strength 1.75%
    Overbought Stochastic Strength 1.75%
    Upper Bollinger Band Touch Strength 1.75%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.86%
    Bollinger Band Squeeze Range Contraction 3.86%
    Older End-of-Day Signals for BCDA ...

       Recent Intraday Alerts

    Alert Time
    Gap Down Closed about 5 hours ago
    Reversed from Down about 5 hours ago
    50 DMA Resistance about 5 hours ago
    1.5x Volume Pace about 5 hours ago
    Gapped Down (Full) about 5 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    BCDA Chart by TradingView
    Basic chart:

    Profile

    BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia. The company is also developing CardiALLO Cell Therapy System, an investigational culture expanded bone marrow derived from mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system; and Morph vascular access product line, which provides catheter products. BioCardia, Inc. is based in San Carlos, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Bone Stem Cell Cell Therapy Catheter Cardiovascular Disease Heart Failure Vascular Disease Regenerative Medicine Heart Disease Vascular Access Products Bone Marrow Aging Associated Diseases Ischemia Treatment Of Heart Failure

    Is BCDA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 9 BioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024
    May 1 BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
    Apr 25 BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
    Apr 2 Insiders Are Buying These 11 Penny Stocks
    Apr 1 BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript
    Mar 29 BioCardia Full Year 2023 Earnings: Misses Expectations
    Mar 28 Q4 2023 BioCardia Inc Earnings Call
    Mar 28 BioCardia, Inc. (BCDA) Q4 2023 Earnings Call Transcript
    Mar 27 BioCardia GAAP EPS of -$0.55 misses by $0.09, revenue of $0.5M misses by $0.2M
    Mar 27 BioCardia: Q4 Earnings Insights
    See more BCDA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.9199
    52 Week Low 0.32
    Average Volume 359,088
    200-Day Moving Average 0.54
    50-Day Moving Average 0.40
    20-Day Moving Average 0.38
    10-Day Moving Average 0.38
    Average True Range 0.02
    RSI (14) 53.92
    ADX 12.02
    +DI 19.58
    -DI 15.00
    Chandelier Exit (Long, 3 ATRs) 0.35
    Chandelier Exit (Short, 3 ATRs) 0.38
    Upper Bollinger Bands 0.39
    Lower Bollinger Band 0.36
    Percent B (%b) 0.99
    BandWidth 9.34
    MACD Line 0.00
    MACD Signal Line -0.01
    MACD Histogram 0.0039
    Fundamentals Value
    Market Cap 9.31 Million
    Num Shares 23.6 Million
    EPS -0.62
    Price-to-Earnings (P/E) Ratio -0.64
    Price-to-Sales 17.62
    Price-to-Book 10.67
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.41
    Resistance 3 (R3) 0.41 0.40 0.41
    Resistance 2 (R2) 0.40 0.40 0.40 0.41
    Resistance 1 (R1) 0.40 0.40 0.40 0.40 0.41
    Pivot Point 0.39 0.39 0.39 0.39 0.39
    Support 1 (S1) 0.39 0.39 0.38 0.39 0.38
    Support 2 (S2) 0.38 0.38 0.38 0.38
    Support 3 (S3) 0.38 0.38 0.38
    Support 4 (S4) 0.38